Glycemic effects of simvastatin: Where do we stand?

ABSTRACT In clinical practice, simvastatin is usually used in the treatment of dyslipidemia patients and those at risk of or with established cardiovascular disease. However, previous studies have shown that simvastatin has the potential to affect glycemic parameters as it reportedly reduced insulin...

Full description

Bibliographic Details
Main Authors: Nor Razida Razali, Hasniza Zaman Huri, Luqman Ibrahim, Shireene Ratna Vethakkan, Bashar Mudhaffar Abdullah
Format: Article
Language:English
Published: Universidade de São Paulo 2018-06-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000100403&lng=en&tlng=en